Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide that regulates stress, blood vessels, and nerve cells. Here's what research shows.
Pituitary adenylate cyclase activating polypeptide (PACAP) is a naturally occurring neuropeptide that helps regulate blood vessels, nerve cells, hormone release, and the body's stress response. It exists mainly as two forms, PACAP-27 and PACAP-38, and it signals through three receptors known as PAC1, VPAC1, and VPAC2. PACAP is not an FDA-approved drug or dietary supplement; it remains a research compound studied for migraine, PTSD, and neuroprotection.
What Is Pituitary Adenylate Cyclase Activating Polypeptide?
PACAP is a short chain of amino acids produced by the ADCYAP1 gene. Scientists first isolated it from the hypothalamus in 1989 while searching for molecules that boost cyclic AMP, a key cellular signal. The name pituitary adenylate cyclase activating polypeptide comes directly from that discovery.
If you are asking what is a polypeptide, the simplest definition is a chain of amino acids linked by peptide bonds. PACAP's polypeptide structure is short, either 27 or 38 amino acids, which places it among peptides rather than full proteins. It is produced in the brain, gut, adrenal glands, and other tissues.
The hyphenated spelling, pituitary adenylate cyclase-activating polypeptide, refers to the same molecule. PACAP belongs to the same polypeptide group as vasoactive intestinal peptide (VIP) and secretin. Common polypeptide names in this family include VIP, secretin, glucagon, and growth hormone-releasing hormone. A different hormone, pancreatic polypeptide, is made in the pancreas and helps regulate digestion and appetite; it is related only by the broad category of peptide hormones.
PACAP-27 vs PACAP-38
Both forms come from the same gene, but they behave differently. PACAP-38 is the dominant form in most human tissues, while PACAP-27 is shorter and more selective for one receptor.
| Feature | PACAP-27 | PACAP-38 |
|---|---|---|
| Amino acids | 27 | 38 |
| Relative abundance | Minor form in most tissues | Dominant form, often about 90% of total PACAP |
| Receptor preference | Strong affinity for PAC1 | Binds PAC1, VPAC1, and VPAC2 |
| Tissue distribution | Mostly nervous system | Brain, gut, adrenal glands, gonads, immune cells |
| Half-life in blood | Very short, often minutes | Short but slightly longer than PACAP-27 |
| Research focus | Potency at PAC1 | Migraine, stress, metabolism, immune signaling |
How PACAP Signals in the Body
PACAP works by binding to G protein-coupled receptors on the surface of cells. That binding raises cyclic AMP inside the cell and triggers a wide range of responses.
- PAC1 (ADCYAP1R1): The primary PACAP receptor. It is heavily expressed in the nervous system and is central to stress and pain research.
- VPAC1: Found in the brain, liver, and immune tissue. It also responds to VIP.
- VPAC2: Involved in smooth muscle relaxation, insulin release, and circadian rhythm.
Because PACAP binds all three receptors, its effects are broad. This is one reason researchers separate its roles by tissue rather than treating it as a single-function molecule.
What Does PACAP Do in the Body?
PACAP acts as both a neurotransmitter and a hormone. Its main known roles include:
- Vasodilation: PACAP relaxes blood vessels and influences blood pressure and blood flow.
- Neuroprotection: In lab and animal studies, PACAP helps protect neurons from injury and oxidative stress.
- Stress response: PACAP helps activate the HPA axis and the body's fight-or-flight chemistry.
- Metabolism: It affects insulin secretion and energy balance.
- Pain and migraine: PACAP levels rise during migraine attacks, and intravenous PACAP can trigger migraine-like headaches in research volunteers.
- Circadian rhythm: PACAP helps set the body's internal clock through signaling in the suprachiasmatic nucleus.
PACAP is also studied in PTSD. Genetic variants near the PAC1 receptor gene have been linked to stress-related symptoms, especially in women, though the findings are not yet used for diagnosis or treatment.
Is PACAP a Medication, Supplement, or Research Chemical?
PACAP is not FDA-approved for human use in the United States. It is not sold as a legal supplement or prescription drug for any condition. Products labeled as PACAP are typically research chemicals sold for laboratory use only.
That distinction matters for safety. Research chemicals are not tested for purity, sterility, or dosing in humans. Injecting an unapproved peptide carries risks such as infection, allergic reactions, and unknown long-term effects. Anyone considering PACAP for a health condition should talk with a licensed healthcare professional instead of self-treating.
Current Research on PACAP
PACAP is an active target in several areas of medicine. Migraine prevention is the most advanced. An anti-PACAP antibody called Lu AG09222 met its primary endpoint in a phase 2 trial for migraine prevention, and earlier PAC1-targeted antibodies have shown mixed results.
Other research areas include:
- Neurodegenerative disease, including Alzheimer's and Parkinson's models.
- PTSD and anxiety, where PACAP signaling may influence fear learning.
- Chronic pain and inflammation.
- Metabolic disorders and insulin regulation.
- Retinal and cardiac protection in animal studies.
Most of these findings come from cells or animals. They do not prove that PACAP treats any human disease. Clinical trials are still early, and no PACAP-based therapy is standard care today.
Key Takeaways
- Pituitary adenylate cyclase activating polypeptide is a natural signaling peptide, not a vitamin or supplement.
- PACAP-38 is the dominant form in humans, and PACAP-27 is the shorter, more PAC1-selective form.
- PACAP acts through PAC1, VPAC1, and VPAC2 receptors and affects blood vessels, nerves, stress hormones, and metabolism.
- PACAP is not FDA-approved for human use, and research chemicals sold online should not be treated as safe medicine.
Frequently Asked Questions
What does PACAP do in the body?
PACAP acts as both a neurotransmitter and a hormone. It dilates blood vessels, supports nerve cell survival, helps trigger the body's stress response, influences insulin release, and plays a role in migraine and circadian rhythm. Its effects depend on which of its three receptors, PAC1, VPAC1, or VPAC2, is activated in a given tissue.
Is PACAP available as a supplement or medication?
No. PACAP is not FDA-approved as a drug and is not a legal dietary supplement in the United States. Products sold as PACAP are research chemicals intended for laboratory use, not human consumption. Taking them is risky because purity, dosing, and safety have not been established.
What is the difference between PACAP-27 and PACAP-38?
Both forms come from the same gene, but PACAP-38 is 38 amino acids long and is the dominant form in most human tissues. PACAP-27 is shorter, less abundant, and binds the PAC1 receptor more selectively. Researchers study PACAP-27 for receptor-specific effects and PACAP-38 for its broader role in stress, migraine, and metabolism.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.